Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma
about
Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin Lymphoma.High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma.Hodgkin lymphoma in the elderly, pregnant, and HIV-infected.A Review of Autologous Stem Cell Transplantation in Lymphoma.Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC).A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.Contrast-enhanced ultrasound in the therapeutic assessment of diffuse large B-cell lymphoma: A case report.Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective study.Current trials for frontline therapy of mantle cell lymphoma.A new "age" for high dose therapy and autologous stem cell transplant.
P2860
Q38539561-28245E8C-BC2B-4E52-86A0-7E0075A5309CQ38552083-BB3D8E25-1C25-49D7-A0B5-3B3159006D51Q38920105-497E94E4-A7E9-4865-B96A-E69B1678314FQ39288544-07C8FD68-DE70-492D-982A-7646F93AF6CBQ39865684-AA8B4605-44C1-4AD7-B0DF-09B8CE6DA1E2Q40551437-4BBA04A5-56E4-4E06-9E50-B8A595998084Q41914086-3E203D29-E120-46DB-BCC3-D2F2178004A8Q44197345-BED99F0B-5B58-459A-8DC1-53F6D9506979Q47237352-CDD075B8-7011-43E4-846D-509C071EB25AQ48234935-8B7DE1E2-9603-4346-A8EF-B0F644CADC48Q49279565-D0B2124F-B818-470D-AEDF-FF028A26857DQ52970815-640F9362-543A-4090-9153-264B7DA7B732
P2860
Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Favorable outcomes in elderly ...... ation for non-Hodgkin lymphoma
@ast
Favorable outcomes in elderly ...... ation for non-Hodgkin lymphoma
@en
type
label
Favorable outcomes in elderly ...... ation for non-Hodgkin lymphoma
@ast
Favorable outcomes in elderly ...... ation for non-Hodgkin lymphoma
@en
prefLabel
Favorable outcomes in elderly ...... ation for non-Hodgkin lymphoma
@ast
Favorable outcomes in elderly ...... ation for non-Hodgkin lymphoma
@en
P2093
P2860
P50
P1476
Favorable outcomes in elderly ...... ation for non-Hodgkin lymphoma
@en
P2093
Andrew D Zelenetz
Craig H Moskowitz
Craig S Sauter
Jenna Goldberg
Jocelyn Maragulia
Michael Scordo
Miguel-Angel Perales
Roni Tamari
Sean M Devlin
Sergio A Giralt
P2860
P304
P356
10.1016/J.BBMT.2014.08.019
P577
2014-08-28T00:00:00Z